CoChat

The most reliable surface marker for the identification of colorectal cancer stem‐like cells: A systematic review and meta‐analysis

Abbasian, Mahdi, Mousavi, Elham, Arab‐Bafrani, Zahra, Sahebkar, Amirhossein · 2019 · Journal of Cellular Physiology
Cited by 38

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Several surface markers have been proposed for the identification and characterization of colorectal cancer stem‐like cells (CR‐CSLCs). However, their reliability in CR‐CSLCs identification remains controversial. This study evaluated the correlation between all candidate surface marker's expression and CSLCs properties (tumorigenicity) through monitoring in vivo tumor incidence and final tumor volume. PubMed, Web of Science, and Scopus databases were systematically searched until November 2017. A total of 27 studies were found that met the inclusion criteria for cluster of differentiation 133 (CD133) and CD44 markers. Results indicated that either CD133 or CD44 positive cells caused about twofold increase in tumor volume compared with the negative cells (p < 0.05). In two groups of cells derived from primary tumors and cell lines, CD133 + cells had 25 and 1.45 times higher tumor incidence potential than CD133 − cells, respectively ( p < 0.05). Also, cohort evaluation showed that CD133 overexpression at protein level is a marker of poor overall survival in colorectal cancer (CRC) patients. While CD44 + cells displayed twofold tumorigenicity compared with the negative cells ( p < 0.05), combination of CD44 and CD133 showed about sevenfold tumorigenicity potential ( p < 0.05). In conclusion, the present meta‐analysis suggests that CD133 is a robust biomarker to identify primary tumor CSLCs and can be proposed as a prognostic marker of CRC patient whereas it should be used with caution in cell lines. It seems to be more reliable to use CD133 in combination with CD44 as target biomarkers for the isolation of CR‐CSLCs in both cell line and primary tumor cells populations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jcp.27619

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • N-Glycans in cancer progression

    Lau, K. S., & Dennis, J. W. (2008) · Glycobiology · doi:10.1093/glycob/cwn071 · Cited by 390 · cited 1×

    “Moreover, changes in glycan structure in various colon cancer cell lines and during tumor progression have been documented (Hakomori, 2002; Holst et al., 2016; Lau & Dennis, 2008).”
    Background

Show all 1 references

Cited by

See all 38

Metadata

Authors
Abbasian, M., Mousavi, E., Arab‐Bafrani, Z., & Sahebkar, A.
Venue
Journal of Cellular Physiology
Publisher
Wiley
Published
2018-10-14
Volume
234
Issue
6
Pages
8192-8202
ISSN
  • 0021-9541 (ISSN-L)
  • 1097-4652
OpenAlex
W2907570231
Cited by
38
References
1
FWCI
0.63
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The most reliable surface marker for the identification of colorectal cancer stem‐like cells: A systematic review and meta‐analysis. https://app.cochat.ai/papers/10.1002/jcp.27619
The paper
Abbasian, M., Mousavi, E., Arab‐Bafrani, Z., & Sahebkar, A. (2019). The most reliable surface marker for the identification of colorectal cancer stem‐like cells: A systematic review and meta‐analysis. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.27619

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.